Salesforce Inc. [NYSE: CRM] gained 0.30% on the last trading session, reaching $160.65 price per share at the time. The company report on October 11, 2022 that Salesforce Has Been Positioned by Gartner in the Leaders Quadrant of the Magic Quadrant for B2B Marketing Automation Platforms for the Fifth Consecutive Year.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Salesforce (NYSE: CRM), the global leader in CRM, today announced it has been positioned by Gartner, Inc. in the “Leaders” quadrant of the 2022 Gartner® Magic Quadrant™ for B2B Marketing Automation Platforms report. The company was evaluated for Salesforce Marketing Cloud Account Engagement, and placed furthest on the “Completeness of Vision” axis.
Gartner defines B2B marketing automation platforms as “software that supports the practice of demand generation. This includes building awareness, generating and nurturing high-quality leads, orchestrating multichannel engagement to guide customer journey progression, and using analytics to measure and optimize performance.”.
Salesforce Inc. represents 997.00 million in outstanding shares, while the company has a total market value of $157.97 billion with the latest information. CRM stock price has been found in the range of $158.3968 to $161.57.
If compared to the average trading volume of 6.62M shares, CRM reached a trading volume of 6215129 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Salesforce Inc. [CRM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRM shares is $220.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRM stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Northland Capital have made an estimate for Salesforce Inc. shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on October 17, 2022. The new note on the price target was released on September 28, 2022, representing the official price target for Salesforce Inc. stock. Previously, the target price had yet another raise to $150, while Guggenheim analysts kept a Neutral rating on CRM stock.
The Average True Range (ATR) for Salesforce Inc. is set at 5.89, with the Price to Sales ratio for CRM stock in the period of the last 12 months amounting to 5.39. The Price to Book ratio for the last quarter was 2.67, with the Price to Cash per share for the same quarter was set at 13.76. Price to Free Cash Flow for CRM in the course of the last twelve months was 27.81 with Quick ratio for the last quarter at 1.10.
Trading performance analysis for CRM stock
Salesforce Inc. [CRM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.15. With this latest performance, CRM shares gained by 9.28% in over the last four-week period, additionally sinking by -7.97% over the last 6 months – not to mention a drop of -45.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRM stock in for the last two-week period is set at 59.51, with the RSI for the last a single of trading hit 67.68, and the three-weeks RSI is set at 54.49 for Salesforce Inc. [CRM]. The present Moving Average for the last 50 days of trading for this stock 158.21, while it was recorded at 157.10 for the last single week of trading, and 183.03 for the last 200 days.
Salesforce Inc. [CRM]: A deeper dive into fundamental analysis
Salesforce Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.10.
Salesforce Inc. [CRM]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Salesforce Inc. go to 15.30%.
An analysis of insider ownership at Salesforce Inc. [CRM]
There are presently around $124,620 million, or 80.10% of CRM stock, in the hands of institutional investors. The top three institutional holders of CRM stocks are: VANGUARD GROUP INC with ownership of 79,345,967, which is approximately 2.222% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 69,085,012 shares of the stock with an approximate value of $11.1 billion in CRM stocks shares; and FMR LLC, currently with $7.87 billion in CRM stock with ownership of nearly -19.339% of the company’s market capitalization.
Positions in Salesforce Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 1,047 institutional holders increased their position in Salesforce Inc. [NYSE:CRM] by around 61,636,895 shares. Additionally, 1,064 investors decreased positions by around 52,835,944 shares, while 199 investors held positions by with 661,251,458 shares. The mentioned changes placed institutional holdings at 775,724,297 shares, according to the latest SEC report filing. CRM stock had 134 new institutional investments in for a total of 10,136,567 shares, while 208 institutional investors sold positions of 6,637,636 shares during the same period.